0001209191-20-063655.txt : 20201215
0001209191-20-063655.hdr.sgml : 20201215
20201215204919
ACCESSION NUMBER: 0001209191-20-063655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201211
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Menard Chrystal
CENTRAL INDEX KEY: 0001564252
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21937
FILM NUMBER: 201391075
MAIL ADDRESS:
STREET 1: C/O CERUS CORPORATION
STREET 2: 2550 STANWELL DRIVE
CITY: CONCORD
STATE: CA
ZIP: 94520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CERUS CORP
CENTRAL INDEX KEY: 0001020214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 680262011
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1220 CONCORD AVENUE
STREET 2: SUITE 600
CITY: CONCORD
STATE: CA
ZIP: 94520
BUSINESS PHONE: 9252886000
MAIL ADDRESS:
STREET 1: 1220 CONCORD AVENUE
STREET 2: SUITE 600
CITY: CONCORD
STATE: CA
ZIP: 94520
FORMER COMPANY:
FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC
DATE OF NAME CHANGE: 19960731
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-11
0
0001020214
CERUS CORP
CERS
0001564252
Menard Chrystal
C/O CERUS CORPORATION
1220 CONCORD AVE SUITE 600
CONCORD
CA
94520
0
1
0
0
Chief Legal Officer
Common Stock
2020-12-11
4
M
0
4167
4.33
A
52742
D
Common Stock
2020-12-11
4
S
0
4167
8.00
D
48585
D
Common Stock
2020-12-11
4
M
0
3959
4.32
A
52544
D
Common Stock
2020-12-11
4
S
0
3959
8.00
D
48585
D
Common Stock
2020-12-11
4
M
0
11362
4.46
A
59947
D
Common Stock
2020-12-11
4
S
0
11362
8.00
D
48585
D
Common Stock
2020-12-11
4
M
0
21875
4.46
A
70460
D
Common Stock
2020-12-11
4
S
0
21875
8.00
D
48585
D
Option (Right to Buy)
4.33
2020-12-11
4
M
0
4167
D
2027-02-28
Common Stock
4167
95833
D
Option (Right to Buy)
4.32
2020-12-11
4
M
0
3959
D
2028-02-28
Common Stock
3959
91041
D
Option (Right to Buy)
4.46
2020-12-11
4
M
0
11362
D
2025-03-01
Common Stock
11362
68516
D
Option (Right to Buy)
4.46
2020-12-11
4
M
0
21875
D
2025-03-01
Common Stock
21875
0
D
This transaction was executed pursuant to a 10b5-1 plan.
One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
Not applicable.
Chrystal Menard
2020-12-15